Page last updated: 2024-08-24

triazoles and cgs 15943

triazoles has been researched along with cgs 15943 in 86 studies

Research

Studies (86)

TimeframeStudies, this research(%)All Research%
pre-19904 (4.65)18.7374
1990's48 (55.81)18.2507
2000's22 (25.58)29.6817
2010's10 (11.63)24.3611
2020's2 (2.33)2.80

Authors

AuthorsStudies
O'Regan, MH; Perkins, LM; Phillis, JW; Simpson, RE1
Cox, BF; Lappe, RW; Sheldon, JH1
Adén, U; Fredholm, BB; Johansson, B; Lindström, K; Svenningsson, P1
Abels, BC; Branch, RA; Callis, JT; Sabra, R1
Barraco, RA; Phillis, JW1
Holtzman, SG; Mumford, GK1
Holtzman, SG3
Czuczwar, SJ; Janusz, W; Kleinrok, Z; Szczepanik, B1
Do, UH; Jarvis, MF; Sills, MA; Williams, M1
Bourguignon, JJ; Griebel, G; Misslin, R; Remmy, D; Saffroy-Spittler, M; Vogel, E1
Brown, GL; Douglas, FL; Kotake, AN; Mustafa, SJ; Sabouni, MH1
Behnke, N; Müller, W; Neumann, J; Schmitz, W; Scholz, H; Stein, B1
Gewirtz, H; Mills, I1
Brubaker, WF; Williams, ED1
Abels, BC; Branch, KR; Branch, RA; Callis, JT; Jackson, EK; Kuan, CJ; Sabra, R1
Braunwalder, A; Cash, WD; Francis, J; Ghai, G; Psychoyos, S; Stone, GA; Williams, M1
Cote, DT; Dotson, RA; Francis, JE; Ghai, G; Goodman, FR; Hopkins, MF; Williams, M; Zimmerman, MB1
Karasawa, A; Kishibayashi, N; Suzuki, M; Tomaru, A1
Amoroso, S; Annunziato, L; Di Renzo, G; Iannotti, E; Saggese, ML1
Howell, LL; Landrum, AM1
Howell, LL1
Imaizumi, M; Miyazaki, S; Onodera, K1
Cazin, L; Mei, YA; Vaudry, H1
Jarvis, JE; Reeves, JJ; Sheehan, MJ; Strong, P1
Borchard, U; Felsch, A; Stöcker, K1
Patel, M; Sheehan, MJ; Strong, P1
Gao, Y; Phillis, JW1
Schmitz, W; Scholz, H; Seeland, C; Stein, B1
Conti, A; Dionisotti, S; Gatta, F; Ongini, E; Sandoli, D; Zocchi, C1
Currin, RT; Lemasters, JJ; Lichtman, SN; Reinstein, LJ; Thurman, RG; Wang, J1
Byrd, LD; Howell, LL1
Kroll, K; Schrader, J1
Ahlberg, S; Fredholm, BB; Olsson, RA; Parkinson, FE; van der Ploeg, I1
Baraldi, PG; Dionisotti, S; Ferrara, S; Ongini, E; Zocchi, C1
di Chiara, G; Morelli, M; Pinna, A; Wardas, J1
Dobson, JG; Fenton, RA; Sawmiller, DR1
Jacobson, KA; Ji, XD; Kim, YC1
Anderson, GF; Barraco, RA; Helfman, CC1
Dobson, JG; Ethier, MF1
Abbracchio, MP; Jacobson, KA; Jiang, JL; Kim, YC; Sei, Y; Yao, Y1
Jones, CA; Reeves, JJ; Sheehan, MJ; Vardey, CJ; Whelan, CJ1
Alexander, SP; Cooper, J; Hill, SJ1
Chang, L; de Zwart, M; IJzerman, AP; Jacobson, KA; Kim, YC; Melman, N; Moro, S; von Frijtag Drabbe Künzel, JK1
Baraldi, PG; Borea, PA; Cacciari, B; Dionisotti, S; Ongini, E; Varani, K1
Cutler, BS; Dobson, JG; Fenton, RA; Li, Jm; Peyton, BD; Powell, CC; Wheeler, HB1
Dionisotti, S; Fredholm, BB; Gessi, S; Irenius, E; Ongini, E1
Fredholm, BB; Johansson, B; Kuzmin, A; Zvartau, EE1
Hata, K; Kloner, RA; Przyklenk, K; Whittaker, P1
Fredholm, BB; Lindström, K1
Borgeat, P; Bourgoin, SG; Harbour, D; Naccache, PH; Thibault, N1
Gean, PW; Lu, KT; Wu, SP1
Coyne, EF; Meno, JR; Ngai, AC; West, GA; Winn, HR1
Chen, Y; Hertz, L; Rathbone, MP1
Hamann, M; Richter, A1
Baldwin, SA; Cass, CE; Duszyk, M; Man, SF; Ng, AM; Sawicka, J; Szkotak, AJ; Young, JD1
Bivalacqua, TJ; Champion, HC; Kadowitz, PJ; Lambert, DG1
Anderson, KE; Daniele, N; Foukas, LC; Jensen, J; Ktori, C; Shepherd, PR1
Le Crom, S; Prou, D; Vernier, P1
Feldkamp, T; Heemann, U; Herget-Rosenthal, S; Horbelt, M; Kribben, A; Lange, B; Philipp, T; Pietruck, F1
Griffiths, RR; Weerts, EM1
Choi, JI; Jeong, SW; Yoon, MH1
Hague, BF; Kindt, TJ; Zhao, TM1
Baur, F; Fozard, JR; Wolber, C1
O'Regan, MH; Phillis, JW1
Chen, A; Gao, ZG; Gross, AS; Jacobson, KA; Kim, SK; Van Calenbergh, S; Van Rompaey, P1
Bennett, MR; Lin, YQ2
Andrisani, OM; Bilodeau, ML; Ji, M; Paris, M1
Sladek, CD; Song, Z1
Holý, A; Kmonícková, E; Potmesil, P; Zídek, Z1
Holý, A; Kmonícková, E; Krecmerová, M; Potmesil, P; Zídek, Z1
Arcella, A; Cantore, G; Di Gennaro, G; Esposito, V; Eusebi, F; Fredholm, BB; Fucile, S; Limatola, C; Manfredi, M; Martinello, K; Mascia, A; Miledi, R; Piccari, V; Quarato, PP; Roseti, C; Simonato, M1
Faldyna, M; Kovaru, F; Kovaru, H; Leva, L; Matiasovic, J; Ondrackova, P1
Fabbretti, E; Giniatullin, R; Lorenzon, P; Luin, E; Parato, G; Ren, E; Sciancalepore, M1
Berg, L; Lopper, ME; Sunchu, B; Ward, HE1
Edling, CE; Falasca, M; Ghonaim, R; Maffucci, T; Selvaggi, F1
Banerjee, J; Civan, MM; Gao, ZG; Jacobson, KA; Kambayashi, T; Leung, CT; Li, A1
Ballanyi, K; Ciechanski, P; Mosca, EV; Roy, A; Scheibli, EC; Wilson, RJ1
Birnbaum, Y; Kodakandla, M; Ling, S; Nanhwan, MK; Nylander, S; Ye, Y1
Alefishat, E; Alexander, SP; Ralevic, V1
Fujii, N; Kadowaki, N; Kanda, J; Kawabata, H; Oishi, S; Sakamoto, S; Takaori-Kondo, A; Tomosugi, N; Uchiyama, T1
Ishikawa, T; Nakamura, M; Nishiyama, R; Saito, SY; Todoroki, K; Toyo'oka, T; Yamaguchi, M1
Kirby, JE; Zulauf, KE1
Jang, HS; Kerkvliet, NI; Kolluri, SK; Liefwalker, DF; O'Donnell, EF1

Other Studies

86 other study(ies) available for triazoles and cgs 15943

ArticleYear
Excitatory transmitter amino acid release from the ischemic rat cerebral cortex: effects of adenosine receptor agonists and antagonists.
    Journal of neurochemistry, 1992, Volume: 58, Issue:5

    Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Aspartic Acid; Brain Ischemia; Cerebral Cortex; Glutamates; Glutamic Acid; Male; Neurotransmitter Agents; Purinergic Antagonists; Quinazolines; Rats; Rats, Inbred Strains; Receptors, Purinergic; Triazoles; Xanthines

1992
Selective adenosine-2 agonist produces both direct and reflex tachycardia in normotensive rats.
    Journal of cardiovascular pharmacology, 1992, Volume: 19, Issue:3

    Topics: Adenosine; Adrenergic beta-Antagonists; Animals; Blood Pressure; Dose-Response Relationship, Drug; Ganglia, Sympathetic; Heart Rate; Male; Purinergic Antagonists; Quinazolines; Rats; Rats, Inbred Strains; Receptors, Purinergic; Sympathetic Nervous System; Triazoles; Vascular Resistance

1992
Evidence that the increase in striatal c-fos following acute high-dose caffeine is not due to direct interaction with striatal adenosine receptors.
    Acta physiologica Scandinavica, 1992, Volume: 146, Issue:4

    Topics: Adenosine; Animals; Caffeine; Corpus Striatum; Dose-Response Relationship, Drug; Genes, fos; Purinergic Antagonists; Quinazolines; Rats; RNA, Messenger; Triazoles; Xanthines

1992
Influence of the adenosine receptor antagonist, CGS 15943A, on renal function after reconstruction of chronic renal artery stenosis in the dog.
    The Journal of pharmacology and experimental therapeutics, 1992, Volume: 262, Issue:1

    Topics: Adenosine; Animals; Constriction, Pathologic; Creatinine; Dogs; Hemodynamics; Kidney; Purinergic Antagonists; Quinazolines; Renal Artery; Renal Circulation; Triazoles

1992
Subtypes of adenosine receptors in the brainstem mediate opposite blood pressure responses.
    Neuropharmacology, 1991, Volume: 30, Issue:4

    Topics: Adenosine; Animals; Antihypertensive Agents; Blood Pressure; Brain Stem; Dose-Response Relationship, Drug; Male; Phenethylamines; Quinazolines; Rats; Rats, Inbred Strains; Receptors, Purinergic; Triazoles; Xanthines

1991
Do adenosinergic substrates mediate methylxanthine effects upon reinforcement thresholds for electrical brain stimulation in the rat?
    Brain research, 1991, May-31, Volume: 550, Issue:1

    Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Brain; Carbolines; Chlordiazepoxide; Electric Stimulation; Hypothalamic Area, Lateral; Male; Midazolam; Phenylisopropyladenosine; Quinazolines; Rats; Rats, Inbred Strains; Receptors, Purinergic; Reinforcement, Psychology; Self Stimulation; Sensory Thresholds; Theophylline; Triazoles

1991
CGS 15943, a nonxanthine adenosine receptor antagonist: effects on locomotor activity of nontolerant and caffeine-tolerant rats.
    Life sciences, 1991, Volume: 49, Issue:21

    Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Caffeine; Dose-Response Relationship, Drug; Drug Tolerance; Male; Motor Activity; Quinazolines; Rats; Rats, Inbred Strains; Triazoles

1991
Influence of CGS 15943 A (a nonxanthine adenosine antagonist) on the protection offered by a variety of antiepileptic drugs against maximal electroshock-induced seizures in mice.
    Journal of neural transmission. General section, 1991, Volume: 86, Issue:2

    Topics: Adenosine; Animals; Anticonvulsants; Disease Susceptibility; Drug Interactions; Electroshock; Epilepsy; Male; Mice; Motor Activity; Quinazolines; Triazoles

1991
Characterization of the binding of a novel nonxanthine adenosine antagonist radioligand, [3H]CGS 15943, to multiple affinity states of the adenosine A1 receptor in the rat cortex.
    Molecular pharmacology, 1991, Volume: 39, Issue:1

    Topics: 2-Chloroadenosine; Adenosine; Animals; Binding, Competitive; Cerebral Cortex; Dose-Response Relationship, Drug; Phenylisopropyladenosine; Purinergic Antagonists; Pyrazoles; Quinazolines; Rats; Receptors, Purinergic; Triazoles; Tritium

1991
Comparison of the behavioural effects of an adenosine A1/A2-receptor antagonist, CGS 15943A, and an A1-selective antagonist, DPCPX.
    Psychopharmacology, 1991, Volume: 103, Issue:4

    Topics: Adenosine; Animals; Behavior, Animal; Dose-Response Relationship, Drug; Exploratory Behavior; Male; Mice; Motor Activity; Purinergic Antagonists; Quinazolines; Triazoles; Xanthines

1991
Effects of CGS-15943A on the relaxations produced by adenosine analogs in human blood vessels.
    European journal of pharmacology, 1990, Oct-23, Volume: 187, Issue:3

    Topics: Adenosine; Adult; Coronary Vessels; Humans; In Vitro Techniques; Mammary Arteries; Middle Aged; Muscle Relaxation; Muscle, Smooth, Vascular; Potassium Chloride; Quinazolines; Saphenous Vein; Theophylline; Triazoles

1990
Differential antagonism by 1,3-dipropylxanthine-8-cyclopentylxanthine and 9-chloro-2-(2-furanyl)-5,6-dihydro-1,2,4-triazolo(1,5-c)quinazolin-5-im ine of the effects of adenosine derivatives in the presence of isoprenaline on contractile response and cycli
    The Journal of pharmacology and experimental therapeutics, 1990, Volume: 254, Issue:3

    Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Cyclic AMP; Drug Interactions; Electric Stimulation; Female; Guinea Pigs; Heart; Isoproterenol; Male; Myocardial Contraction; Quinazolines; Receptors, Purinergic; Triazoles; Vasodilator Agents; Xanthines

1990
Cultured vascular smooth muscle cells from porcine coronary artery possess A1 and A2 adenosine receptor activity.
    Biochemical and biophysical research communications, 1990, May-16, Volume: 168, Issue:3

    Topics: Adenosine; Adenylyl Cyclase Inhibitors; Analysis of Variance; Animals; Cells, Cultured; Coronary Vessels; Muscle, Smooth, Vascular; Phenylisopropyladenosine; Quinazolines; Receptors, Purinergic; Swine; Triazoles

1990
Rapid, high-sensitivity reversed-phase liquid chromatographic assay for 9-chloro-2-(2-furyl) [1,2,4]triazolo[1,5-c]quinazolin-5-imine and its oxo metabolite in plasma using fluorescence detection.
    Journal of chromatography, 1989, Nov-24, Volume: 496, Issue:2

    Topics: Animals; Chemical Phenomena; Chemistry; Chromatography, High Pressure Liquid; Hydrogen-Ion Concentration; Male; Purinergic Antagonists; Quinazolines; Rats; Rats, Inbred Strains; Spectrometry, Fluorescence; Triazoles

1989
Inhibition of renal vasoconstriction induced by intrarenal hypertonic saline by the nonxanthine adenosine antagonist CGS 15943A.
    The Journal of pharmacology and experimental therapeutics, 1989, Volume: 248, Issue:3

    Topics: Adenosine; Animals; Dogs; Quinazolines; Receptors, Purinergic; Renal Circulation; Saline Solution, Hypertonic; Sodium Chloride; Theophylline; Triazoles; Vasoconstriction

1989
Biochemical characterization of the triazoloquinazoline, CGS 15943, a novel, non-xanthine adenosine antagonist.
    The Journal of pharmacology and experimental therapeutics, 1987, Volume: 241, Issue:2

    Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Binding, Competitive; Brain; Guinea Pigs; Kinetics; Neurotransmitter Agents; Pyrazoles; Quinazolines; Rats; Receptors, Purinergic; Triazoles; Xanthines

1987
Pharmacological characterization of CGS 15943A: a novel nonxanthine adenosine antagonist.
    The Journal of pharmacology and experimental therapeutics, 1987, Volume: 242, Issue:3

    Topics: 2-Chloroadenosine; Adenosine; Animals; Blood Pressure; Coronary Vessels; Dose-Response Relationship, Drug; Guinea Pigs; In Vitro Techniques; Male; Myocardial Contraction; Quinazolines; Rats; Rats, Inbred Strains; Receptors, Purinergic; Trachea; Triazoles

1987
Effects of the adenosine A1-receptor antagonist on defecation, small intestinal propulsion and gastric emptying in rats.
    Japanese journal of pharmacology, 1995, Volume: 68, Issue:1

    Topics: Adamantane; Animals; Bisacodyl; Defecation; Gastric Emptying; Gastrointestinal Motility; Imidazoles; Intestine, Small; Male; Purinergic P1 Receptor Antagonists; Pyrazines; Quinazolines; Rats; Rats, Sprague-Dawley; Triazoles; Xanthines

1995
The A1 agonist CCPA reduced bisoxonol-monitored membrane potential depolarization elicited by high K+ in cerebrocortical nerve endings.
    Biochimica et biophysica acta, 1995, Oct-04, Volume: 1239, Issue:1

    Topics: Adenosine; Animals; Cerebral Cortex; Fluorescent Dyes; Male; Membrane Potentials; Nerve Endings; Phenethylamines; Potassium; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Quinazolines; Rats; Rats, Wistar; Synaptosomes; Thiobarbiturates; Triazoles; Veratridine; Xanthines

1995
Attenuation of hypoxia-induced increases in ventilation by adenosine antagonists in rhesus monkeys.
    Life sciences, 1995, Volume: 57, Issue:8

    Topics: Adenosine; Animals; Hypoxia; Macaca mulatta; Male; Phosphodiesterase Inhibitors; Pyrrolidinones; Quinazolines; Respiration; Rolipram; Triazoles

1995
Comparative effects of caffeine and selective phosphodiesterase inhibitors on respiration and behavior in rhesus monkeys.
    The Journal of pharmacology and experimental therapeutics, 1993, Volume: 266, Issue:2

    Topics: 1-Methyl-3-isobutylxanthine; Animals; Behavior, Animal; Caffeine; Carbon Dioxide; Conditioning, Psychological; Female; Macaca mulatta; Male; Phosphodiesterase Inhibitors; Quinazolines; Respiration; Triazoles

1993
Effects of a non-xanthine adenosine antagonist, CGS 15943, and a phosphodiesterase inhibitor, Ro 20-1724, in a light/dark test in mice.
    Methods and findings in experimental and clinical pharmacology, 1994, Volume: 16, Issue:10

    Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Adenosine; Animals; Anxiety; Darkness; Light; Male; Mice; Mice, Inbred ICR; Motor Activity; Phosphodiesterase Inhibitors; Quinazolines; Triazoles

1994
Inhibitory effect of adenosine on electrical activity of frog melanotrophs mediated through A1 purinergic receptors.
    The Journal of physiology, 1994, Dec-01, Volume: 481 ( Pt 2)

    Topics: Action Potentials; Adenosine; alpha-MSH; Animals; Cells, Cultured; Electrophysiology; Guanosine 5'-O-(3-Thiotriphosphate); Guanosine Triphosphate; Male; Membrane Potentials; Patch-Clamp Techniques; Pertussis Toxin; Phenylisopropyladenosine; Pituitary Gland; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Quinazolines; Rana ridibunda; Tachyphylaxis; Theophylline; Triazoles; Virulence Factors, Bordetella

1994
Further investigations into adenosine A1 receptor-mediated contraction in rat colonic muscularis mucosae and its augmentation by certain alkylxanthine antagonists.
    British journal of pharmacology, 1995, Volume: 114, Issue:5

    Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Colon; Cyclooxygenase Inhibitors; In Vitro Techniques; Indomethacin; Intestinal Mucosa; Muscle Contraction; Muscle, Smooth; Phosphodiesterase Inhibitors; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Quinazolines; Rats; Theophylline; Triazoles; Vasodilator Agents; Xanthines

1995
Adenosine A1 and A2 receptor agonists alter cardiac functions and prostacyclin release in the isolated guinea-pig heart.
    European journal of pharmacology, 1994, Oct-03, Volume: 263, Issue:3

    Topics: 6-Ketoprostaglandin F1 alpha; Adenosine; Animals; Antihypertensive Agents; Cardiac Pacing, Artificial; Cells, Cultured; Coronary Circulation; Dose-Response Relationship, Drug; Endothelium, Vascular; Epoprostenol; Guinea Pigs; Heart; Heart Rate; Male; Myocardium; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Quinazolines; Triazoles; Vasodilation; Ventricular Function, Left; Xanthines

1994
Failure of CGS15943A to block the hypotensive action of agonists acting at the adenosine A3 receptor.
    British journal of pharmacology, 1994, Volume: 113, Issue:3

    Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Blood Pressure; Female; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Quinazolines; Rats; Rats, Wistar; Triazoles

1994
CGS 15943, an adenosine A2 receptor antagonist, reduces cerebral ischemic injury in the Mongolian gerbil.
    Life sciences, 1994, Volume: 55, Issue:3

    Topics: Animals; Brain Ischemia; Gerbillinae; Male; Motor Activity; Purinergic P1 Receptor Antagonists; Pyramidal Cells; Quinazolines; Triazoles

1994
Pharmacological characterization of A2-adenosine receptors in guinea-pig ventricular cardiomyocytes.
    Journal of molecular and cellular cardiology, 1994, Volume: 26, Issue:3

    Topics: Adenosine; Adenylate Cyclase Toxin; Adenylyl Cyclases; Animals; Cells, Cultured; Cyclic AMP; Drug Interactions; Female; Guinea Pigs; Heart Ventricles; Isoproterenol; Male; Myocardial Contraction; Myocardium; Papillary Muscles; Pertussis Toxin; Phenethylamines; Quinazolines; Receptors, Adrenergic, beta; Receptors, Purinergic P1; Signal Transduction; Triazoles; Virulence Factors, Bordetella; Xanthines

1994
Effects of the new A2 adenosine receptor antagonist 8FB-PTP, an 8 substituted pyrazolo-triazolo-pyrimidine, on in vitro functional models.
    British journal of pharmacology, 1994, Volume: 112, Issue:2

    Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Cattle; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Phosphoric Diester Hydrolases; Platelet Aggregation; Purinergic P1 Receptor Antagonists; Pyrimidines; Quinazolines; Rabbits; Rats; Rats, Sprague-Dawley; Triazoles; Vasodilator Agents; Xanthines

1994
Suppression of lipopolysaccharide-stimulated release of tumor necrosis factor by adenosine: evidence for A2 receptors on rat Kupffer cells.
    Hepatology (Baltimore, Md.), 1994, Volume: 19, Issue:6

    Topics: Adenosine; Alprostadil; Animals; Bucladesine; Cells, Cultured; Cyclic AMP; Kupffer Cells; Lipopolysaccharides; Nisoldipine; Quinazolines; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Triazoles; Tumor Necrosis Factor-alpha; Xanthines

1994
Effects of CGS 15943, a nonxanthine adenosine antagonist, on behavior in the squirrel monkey.
    The Journal of pharmacology and experimental therapeutics, 1993, Volume: 267, Issue:1

    Topics: Animals; Behavior, Animal; Caffeine; Drug Interactions; Drug Synergism; Male; Purinergic P1 Receptor Antagonists; Pyrrolidinones; Quinazolines; Receptors, Purinergic P1; Rolipram; Saimiri; Time Factors; Triazoles

1993
Myocardial adenosine stimulates release of cyclic adenosine monophosphate from capillary endothelial cells in guinea pig heart.
    Pflugers Archiv : European journal of physiology, 1993, Volume: 423, Issue:3-4

    Topics: Adenosine; Adenosine Deaminase; Adenosine Triphosphate; Alprostadil; Animals; Capillaries; Coronary Vessels; Cyclic AMP; Endothelium, Vascular; Guinea Pigs; Myocardium; Oxygen; Procaterol; Quinazolines; Theophylline; Triazoles; Vasodilation

1993
Discriminative effects of CGS 15943, a competitive adenosine receptor antagonist, in monkeys: comparison to methylxanthines.
    The Journal of pharmacology and experimental therapeutics, 1996, Volume: 277, Issue:2

    Topics: 1-Methyl-3-isobutylxanthine; Animals; Discrimination Learning; Dose-Response Relationship, Drug; Male; Purinergic P1 Receptor Antagonists; Quinazolines; Saimiri; Theophylline; Triazoles; Xanthines

1996
Functional characterization of adenosine A2 receptors in Jurkat cells and PC12 cells using adenosine receptor agonists.
    Naunyn-Schmiedeberg's archives of pharmacology, 1996, Volume: 353, Issue:3

    Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Amino Acid Sequence; Animals; Base Sequence; Binding, Competitive; Colforsin; Cyclic AMP; DNA; Humans; Isotope Labeling; Lethal Dose 50; Leukemia, T-Cell; Molecular Sequence Data; PC12 Cells; Phenethylamines; Polymerase Chain Reaction; Purinergic P1 Receptor Agonists; Quinazolines; Rats; Receptors, Purinergic P1; RNA, Messenger; Triazoles; Tumor Cells, Cultured

1996
Binding of the radioligand [3H]-SCH 58261, a new non-xanthine A2A adenosine receptor antagonist, to rat striatal membranes.
    British journal of pharmacology, 1996, Volume: 117, Issue:7

    Topics: Adenosine; Animals; Binding, Competitive; Corpus Striatum; In Vitro Techniques; Kinetics; Male; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Pyrimidines; Quinazolines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Triazoles; Tritium

1996
Blockade of A2a adenosine receptors positively modulates turning behaviour and c-Fos expression induced by D1 agonists in dopamine-denervated rats.
    The European journal of neuroscience, 1996, Volume: 8, Issue:6

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Denervation; Male; Motor Activity; Nerve Tissue Proteins; Oxidopamine; Proto-Oncogene Proteins c-fos; Purinergic P1 Receptor Antagonists; Pyrimidines; Quinazolines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Rotation; Triazoles; Xanthines

1996
Myocardial adenosine A1 and A2 receptor activities during juvenile and adult stages of development.
    The American journal of physiology, 1996, Volume: 271, Issue:1 Pt 2

    Topics: Adenosine; Aging; Animals; Coronary Vessels; Drug Synergism; Heart; Isoproterenol; Male; Myocardial Contraction; Myocardium; Osmolar Concentration; Purinergic P1 Receptor Antagonists; Quinazolines; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Triazoles; Veins; Xanthines

1996
Derivatives of the triazoloquinazoline adenosine antagonist (CGS15943) are selective for the human A3 receptor subtype.
    Journal of medicinal chemistry, 1996, Oct-11, Volume: 39, Issue:21

    Topics: Adenosine; Affinity Labels; Animals; Binding Sites; Binding, Competitive; Cell Line; Cerebral Cortex; Corpus Striatum; Humans; Magnetic Resonance Spectroscopy; Quinazolines; Rats; Receptors, Purinergic P1; Structure-Activity Relationship; Substrate Specificity; Triazoles

1996
Augmented release of serotonin by adenosine A2a receptor activation and desensitization by CGS 21680 in the rat nucleus tractus solitarius.
    Brain research, 1996, Sep-16, Volume: 733, Issue:2

    Topics: Adenosine; Animals; In Vitro Techniques; Kinetics; Male; Phenethylamines; Purinergic P1 Receptor Agonists; Quinazolines; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Serotonin; Solitary Nucleus; Triazoles; Xanthines

1996
Adenosine stimulation of DNA synthesis in human endothelial cells.
    The American journal of physiology, 1997, Volume: 272, Issue:3 Pt 2

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; 1-Methyl-3-isobutylxanthine; Adenosine; Adenosine Triphosphate; Cells, Cultured; Colforsin; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; DNA; Endothelium, Vascular; Humans; Kinetics; Poly A; Purinergic P1 Receptor Antagonists; Quinazolines; Tetradecanoylphorbol Acetate; Thioinosine; Thionucleotides; Thymidine; Triazoles; Umbilical Veins

1997
Adenosine A3 receptor agonists protect HL-60 and U-937 cells from apoptosis induced by A3 antagonists.
    Biochemical and biophysical research communications, 1997, Mar-17, Volume: 232, Issue:2

    Topics: Adenosine; Apoptosis; Dihydropyridines; DNA Fragmentation; Dose-Response Relationship, Drug; HL-60 Cells; Humans; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Pyrazoles; Quinazolines; Triazoles

1997
Adenosine A3 receptors promote degranulation of rat mast cells both in vitro and in vivo.
    Inflammation research : official journal of the European Histamine Research Society ... [et al.], 1997, Volume: 46, Issue:5

    Topics: Adenosine; Administration, Cutaneous; Animals; Blood Proteins; Cell Degranulation; Cyproheptadine; Dinitrophenols; Female; Humans; In Vitro Techniques; Injections, Intravenous; Male; Mast Cells; Mice; p-Methoxy-N-methylphenethylamine; Pleura; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Quinazolines; Rats; Rats, Wistar; Receptors, Purinergic P1; Serotonin; Serotonin Antagonists; Serum Albumin; Skin; Theophylline; Triazoles; Xanthines

1997
An endogenous A2B adenosine receptor coupled to cyclic AMP generation in human embryonic kidney (HEK 293) cells.
    British journal of pharmacology, 1997, Volume: 122, Issue:3

    Topics: 2-Chloroadenosine; Adenosine; Adenosine-5'-(N-ethylcarboxamide); Cells, Cultured; Cyclic AMP; DNA, Complementary; Gene Amplification; Humans; In Vitro Techniques; Kidney; Phenethylamines; Polymerase Chain Reaction; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Quinazolines; Receptor, Adenosine A2B; Receptors, Purinergic P1; Triazoles

1997
Derivatives of the triazoloquinazoline adenosine antagonist (CGS 15943) having high potency at the human A2B and A3 receptor subtypes.
    Journal of medicinal chemistry, 1998, Jul-16, Volume: 41, Issue:15

    Topics: Animals; Cerebral Cortex; CHO Cells; Cricetinae; Cyclic AMP; Humans; Models, Molecular; Molecular Conformation; Protein Conformation; Purinergic P1 Receptor Antagonists; Quinazolines; Rats; Receptor, Adenosine A2A; Receptor, Adenosine A2B; Receptor, Adenosine A3; Receptors, Purinergic P1; Recombinant Proteins; Structure-Activity Relationship; Triazoles

1998
Binding affinity of adenosine receptor agonists and antagonists at human cloned A3 adenosine receptors.
    Life sciences, 1998, Volume: 63, Issue:5

    Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Binding, Competitive; Cell Line; Cloning, Molecular; Humans; Kidney; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Pyrimidines; Quinazolines; Receptor, Adenosine A3; Receptors, Purinergic P1; Transfection; Triazines; Triazoles

1998
Adenosine A2a receptors increase arterial endothelial cell nitric oxide.
    The Journal of surgical research, 1998, Volume: 80, Issue:2

    Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Carotid Arteries; Cells, Cultured; Endothelium, Vascular; Humans; Iliac Artery; Nitric Oxide; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Quinazolines; Receptor, Adenosine A2A; Receptors, Purinergic P1; Swine; Triazines; Triazoles; Xanthines

1998
Comparison of CGS 15943, ZM 241385 and SCH 58261 as antagonists at human adenosine receptors.
    Naunyn-Schmiedeberg's archives of pharmacology, 1999, Volume: 359, Issue:1

    Topics: Animals; Cell Line; CHO Cells; Cricetinae; Cyclic AMP; Humans; Purinergic P1 Receptor Antagonists; Pyrimidines; Quinazolines; Rats; Transfection; Triazines; Triazoles; Xanthines

1999
Caffeine, acting on adenosine A(1) receptors, prevents the extinction of cocaine-seeking behavior in mice.
    The Journal of pharmacology and experimental therapeutics, 1999, Volume: 290, Issue:2

    Topics: Animals; Behavior, Animal; Caffeine; Cocaine; Extinction, Psychological; Male; Mice; Mice, Inbred DBA; Purinergic P1 Receptor Antagonists; Pyrimidines; Quinazolines; Reward; Substance Abuse, Intravenous; Theophylline; Triazoles; Xanthines

1999
Discriminative effects of CGS 15943, a competitive adenosine receptor antagonist, have a dopamine component in monkeys.
    European journal of pharmacology, 1999, Jul-02, Volume: 376, Issue:1-2

    Topics: Animals; Cocaine; Dextroamphetamine; Discrimination Learning; Dopamine; Dopamine Agonists; Dopamine Antagonists; Generalization, Stimulus; Male; Morphine; Neurons; Norepinephrine; Phencyclidine; Purinergic P1 Receptor Antagonists; Quinazolines; Receptor, Adenosine A2A; Receptors, Biogenic Amine; Saimiri; Selective Serotonin Reuptake Inhibitors; Triazoles

1999
Brief myocardial ischemia attenuates platelet thrombosis in remote, damaged, and stenotic carotid arteries.
    Circulation, 1999, Aug-24, Volume: 100, Issue:8

    Topics: Adenosine; Animals; Blood Platelets; Carotid Artery Thrombosis; Carotid Stenosis; Dogs; Myocardial Ischemia; Quinazolines; Rabbits; Receptors, Purinergic P1; Triazoles; Vascular Patency

1999
Autoradiographic comparison of the potency of several structurally unrelated adenosine receptor antagonists at adenosine A1 and A(2A) receptors.
    European journal of pharmacology, 1999, Sep-10, Volume: 380, Issue:2-3

    Topics: Adenosine; Animals; Autoradiography; Binding, Competitive; Brain; Caffeine; In Vitro Techniques; Male; Phenethylamines; Purinergic P1 Receptor Antagonists; Pyrazines; Quinazolines; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Receptors, Purinergic P1; Theophylline; Triazines; Triazoles; Tritium; Xanthines

1999
Adenosine receptor occupancy suppresses chemoattractant-induced phospholipase D activity by diminishing membrane recruitment of small GTPases.
    Blood, 2000, Jan-15, Volume: 95, Issue:2

    Topics: Adenosine; Adenosine Deaminase; Adenosine-5'-(N-ethylcarboxamide); ADP-Ribosylation Factor 1; Adult; Caffeine; Cell Membrane; Enzyme Activation; GTP Phosphohydrolases; Humans; In Vitro Techniques; Isoenzymes; Kinetics; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Phenethylamines; Phospholipase D; Protein Kinase C; Protein Kinase C-alpha; Purinergic P1 Receptor Antagonists; Quinazolines; Receptor, Adenosine A2A; Receptors, Purinergic P1; rhoA GTP-Binding Protein; Triazoles

2000
Promotion of forskolin-induced long-term potentiation of synaptic transmission by caffeine in area CA1 of the rat hippocampus.
    The Chinese journal of physiology, 1999, Dec-31, Volume: 42, Issue:4

    Topics: Adenosine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Caffeine; Central Nervous System Stimulants; Colforsin; Cyclic AMP; Drug Synergism; Excitatory Postsynaptic Potentials; Hippocampus; Long-Term Potentiation; Male; Quinazolines; Rats; Rats, Sprague-Dawley; Synaptic Transmission; Triazoles; Xanthines

1999
Receptor subtypes mediating adenosine-induced dilation of cerebral arterioles.
    American journal of physiology. Heart and circulatory physiology, 2001, Volume: 280, Issue:5

    Topics: Adenosine; Adenosine Triphosphate; Animals; Antihypertensive Agents; Arterioles; Cerebrovascular Circulation; Dose-Response Relationship, Drug; In Vitro Techniques; Male; Phenethylamines; Quinazolines; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Triazines; Triazoles; Vasodilation

2001
Guanosine-induced increase in free cytosolic calcium concentration in mouse astrocytes in primary cultures: does it act on an A3 adenosine receptor?
    Journal of neuroscience research, 2001, Jul-15, Volume: 65, Issue:2

    Topics: Adenosine; Animals; Astrocytes; Brain; Calcium; Cells, Cultured; Cytosol; Dose-Response Relationship, Drug; Extracellular Space; Guanosine; Mice; Phosphodiesterase Inhibitors; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Quinazolines; Receptor, Adenosine A3; Receptors, Purinergic P1; Theophylline; Triazoles; Xanthines

2001
Effects of adenosine receptor agonists and antagonists in a genetic animal model of primary paroxysmal dystonia.
    British journal of pharmacology, 2001, Volume: 134, Issue:2

    Topics: Adenosine; Animals; Caffeine; Cricetinae; Disease Models, Animal; Dose-Response Relationship, Drug; Dystonia; Female; Male; Mesocricetus; Muscle Contraction; Mutation; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Quinazolines; Theobromine; Theophylline; Triazines; Triazoles; Xanthines

2001
Regulation of K(+) current in human airway epithelial cells by exogenous and autocrine adenosine.
    American journal of physiology. Cell physiology, 2001, Volume: 281, Issue:6

    Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Adenosine; Affinity Labels; Amiloride; Autocrine Communication; Cell Line; Cell Polarity; Clotrimazole; Diuretics; Epithelial Cells; Equilibrative Nucleoside Transporter 1; Equilibrative-Nucleoside Transporter 2; Growth Inhibitors; Humans; Membrane Transport Proteins; Patch-Clamp Techniques; Potassium; Potassium Channels; Quinazolines; Receptors, Purinergic P1; Respiratory Mucosa; Theobromine; Thioinosine; Triazoles; Uridine; Xanthines

2001
Vasodilator responses to adenosine and hyperemia are mediated by A(1) and A(2) receptors in the cat vascular bed.
    American journal of physiology. Regulatory, integrative and comparative physiology, 2002, Volume: 282, Issue:6

    Topics: Adenosine; Adenosine Triphosphate; Animals; Cats; Dose-Response Relationship, Drug; Female; Hemodynamics; Hindlimb; Hyperemia; Male; Perfusion; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Quinazolines; Receptors, Purinergic P1; Triazoles; Vascular Resistance; Vasodilation; Xanthines

2002
Direct effects of caffeine and theophylline on p110 delta and other phosphoinositide 3-kinases. Differential effects on lipid kinase and protein kinase activities.
    The Journal of biological chemistry, 2002, Oct-04, Volume: 277, Issue:40

    Topics: 1-Methyl-3-isobutylxanthine; Animals; Biological Transport; Caffeine; CHO Cells; Cricetinae; Deoxyglucose; Dimerization; Flavins; Glucose; Kinetics; Monosaccharide Transport Proteins; Phosphatidylinositol 3-Kinases; Phosphorylation; Quinazolines; Recombinant Fusion Proteins; Theophylline; Transfection; Triazoles

2002
Autocrine activation of adenosine A1 receptors blocks D1A but not D1B dopamine receptor desensitization.
    Journal of neurochemistry, 2002, Volume: 82, Issue:6

    Topics: Adenosine; Animals; Autocrine Communication; Cell Line; COS Cells; Cyclic AMP; Dopamine Agonists; Fibroblasts; Mice; Phosphodiesterase Inhibitors; Quinazolines; Receptors, Dopamine D1; Receptors, Dopamine D5; Receptors, Purinergic P1; Time Factors; Transfection; Triazoles; Xanthines

2002
ATP protects, by way of receptor-mediated mechanisms, against hypoxia-induced injury in renal proximal tubules.
    The Journal of laboratory and clinical medicine, 2003, Volume: 141, Issue:1

    Topics: Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Energy Metabolism; Hemolysis; Hypotonic Solutions; Hypoxia; Kidney Tubules, Proximal; Kinetics; L-Lactate Dehydrogenase; Male; Potassium; Quinazolines; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2; Thionucleotides; Triazoles

2003
The adenosine receptor antagonist CGS15943 reinstates cocaine-seeking behavior and maintains self-administration in baboons.
    Psychopharmacology, 2003, Volume: 168, Issue:1-2

    Topics: Animals; Behavior, Addictive; Cocaine; Dose-Response Relationship, Drug; Male; Papio; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Quinazolines; Receptors, Purinergic P1; Self Administration; Triazoles

2003
Spinal gabapentin and antinociception: mechanisms of action.
    Journal of Korean medical science, 2003, Volume: 18, Issue:2

    Topics: Acetates; Adrenergic alpha-Antagonists; Adrenergic Antagonists; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Amines; Analgesics; Animals; Atropine; Cyclohexanecarboxylic Acids; Dihydroergocristine; Enzyme Inhibitors; Excitatory Amino Acid Agonists; GABA Antagonists; Gabapentin; gamma-Aminobutyric Acid; Injections, Spinal; Leucine; Male; Mecamylamine; Muscarinic Antagonists; N-Methylaspartate; Naloxone; Narcotic Antagonists; Nicotinic Antagonists; Pain Measurement; Quinazolines; Rats; Rats, Sprague-Dawley; Serine; Spinal Cord; Thapsigargin; Triazoles

2003
Binding of HTLV-1 virions to T cells occurs by a temperature and calcium-dependent process and is blocked by certain type 2 adenosine receptor antagonists.
    Virus research, 2003, Volume: 93, Issue:1

    Topics: 2-Chloroadenosine; Adenosine; Adenosine-5'-(N-ethylcarboxamide); Antibodies, Monoclonal; Calcium; Cations, Divalent; Cell Line, Transformed; Human T-lymphotropic virus 1; Humans; Kinetics; Membrane Microdomains; Phenethylamines; Purinergic P1 Receptor Agonists; Quinazolines; T-Lymphocytes; Thermodynamics; Triazoles

2003
Antagonist pharmacology of adenosine A2B receptors from rat, guinea pig and dog.
    European journal of pharmacology, 2003, Aug-15, Volume: 475, Issue:1-3

    Topics: Adenosine A2 Receptor Antagonists; Adenosine-5'-(N-ethylcarboxamide); Animals; Dogs; Dose-Response Relationship, Drug; Female; Guinea Pigs; In Vitro Techniques; Male; Muscle Relaxation; Quinazolines; Rats; Receptor, Adenosine A2B; Species Specificity; Triazoles

2003
Effects of adenosine receptor antagonists on pial arteriolar dilation during carbon dioxide inhalation.
    European journal of pharmacology, 2003, Aug-29, Volume: 476, Issue:3

    Topics: Adenosine; Administration, Inhalation; Animals; Caffeine; Carbon Dioxide; Cerebral Cortex; Cerebral Veins; Cerebrovascular Circulation; Drug Interactions; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Purinergic P1 Receptor Antagonists; Quinazolines; Rats; Rats, Sprague-Dawley; Triazines; Triazoles; Vasodilation; Vasodilator Agents; Xanthines

2003
Modeling the adenosine receptors: comparison of the binding domains of A2A agonists and antagonists.
    Journal of medicinal chemistry, 2003, Nov-06, Volume: 46, Issue:23

    Topics: Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Adenosine-5'-(N-ethylcarboxamide); Animals; Binding Sites; COS Cells; Humans; Hydrogen Bonding; Hydrophobic and Hydrophilic Interactions; Ligands; Models, Molecular; Mutagenesis, Site-Directed; Protein Conformation; Quinazolines; Radioligand Assay; Receptors, Adenosine A2; Triazoles

2003
Varicosity-Schwann cell interactions mediated by ATP in the mouse vas deferens.
    Journal of neurophysiology, 2005, Volume: 93, Issue:5

    Topics: Adenosine Triphosphate; Adrenergic Fibers; Aniline Compounds; Animals; Caffeine; Calcium; Cell Count; Drug Interactions; Electric Stimulation; Estrenes; Evoked Potentials; Fluorescent Dyes; Immunohistochemistry; In Vitro Techniques; Male; Mice; Mice, Inbred BALB C; Organic Chemicals; Phosphodiesterase Inhibitors; Platelet Aggregation Inhibitors; Pyridoxal Phosphate; Pyrrolidinones; Quinazolines; S100 Proteins; Schwann Cells; Suramin; Time Factors; Triazoles; Uridine Triphosphate; Vas Deferens; Xanthenes

2005
Adenosine signaling promotes neuronal, catecholaminergic differentiation of primary neural crest cells and CNS-derived CAD cells.
    Molecular and cellular neurosciences, 2005, Volume: 29, Issue:3

    Topics: 1-Methyl-3-isobutylxanthine; Adenosine; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Adenosine Deaminase; Adenosine Deaminase Inhibitors; Adenosine-5'-(N-ethylcarboxamide); Adrenal Medulla; Animals; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Catecholamines; Cell Differentiation; Cell Line; Cells, Cultured; Chromaffin Cells; Coturnix; Culture Media, Serum-Free; Cyclic AMP; Neural Crest; Neurons; Quinazolines; Receptor, Adenosine A2A; Receptor, Adenosine A2B; Signal Transduction; Sympathetic Nervous System; Transforming Growth Factor beta; Triazoles; Tyrosine 3-Monooxygenase

2005
Does conversion of ATP to adenosine terminate ATP-stimulated vasopressin release from hypothalamo-neurohypophyseal explants?
    Brain research, 2005, Jun-14, Volume: 1047, Issue:1

    Topics: 5'-Nucleotidase; Adenosine; Adenosine A1 Receptor Antagonists; Adenosine Triphosphate; Animals; Enzyme Inhibitors; Hypothalamo-Hypophyseal System; Male; Organ Culture Techniques; Pituitary Gland, Posterior; Purinergic P1 Receptor Antagonists; Quinazolines; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A1; Receptors, Purinergic P1; Supraoptic Nucleus; Time Factors; Triazoles; Vasopressins; Water-Electrolyte Balance; Xanthines

2005
Purine P1 receptor-dependent immunostimulatory effects of antiviral acyclic analogues of adenine and 2,6-diaminopurine.
    European journal of pharmacology, 2006, Jan-13, Volume: 530, Issue:1-2

    Topics: 2-Aminopurine; Adenine; Adjuvants, Immunologic; Animals; Anti-HIV Agents; Caffeine; Cell Survival; Cells, Cultured; Chemokine CCL3; Chemokine CCL4; Chemokine CCL5; Dihydropyridines; Dose-Response Relationship, Drug; Female; Flavins; Humans; Interleukin-10; Lipopolysaccharides; Macrophage Inflammatory Proteins; Macrophages; Mice; Mice, Inbred C57BL; Molecular Structure; Organophosphonates; Purinergic P1 Receptor Antagonists; Quinazolines; Receptors, Purinergic P1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Theophylline; Triazoles; Tumor Necrosis Factor-alpha

2006
Schwann cells in rat vascular autonomic nerves activated via purinergic receptors.
    Neuroreport, 2006, Apr-03, Volume: 17, Issue:5

    Topics: Adenosine; Adenosine Triphosphate; Animals; Autonomic Nervous System; Calcium; Quinazolines; Rats; Rats, Wistar; Receptors, Purinergic; Schwann Cells; Splanchnic Circulation; Suramin; Triazoles; Uridine Triphosphate

2006
Nucleotide analogues with immunobiological properties: 9-[2-Hydroxy-3-(phosphonomethoxy)propyl]-adenine (HPMPA), -2,6-diaminopurine (HPMPDAP), and their N6-substituted derivatives.
    European journal of pharmacology, 2006, Jul-01, Volume: 540, Issue:1-3

    Topics: Adenine; Animals; Caffeine; Cell Survival; Cytokines; Dihydropyridines; Dose-Response Relationship, Drug; Female; Gene Expression; Interferon-gamma; Lipopolysaccharides; Macrophages, Peritoneal; Mice; Mice, Inbred C57BL; Molecular Structure; Nitric Oxide; Nitric Oxide Synthase Type II; Nucleotides; Organophosphonates; Organophosphorus Compounds; Purinergic P1 Receptor Antagonists; Quinazolines; Receptors, Purinergic P1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Triazoles

2006
Adenosine receptor antagonists alter the stability of human epileptic GABAA receptors.
    Proceedings of the National Academy of Sciences of the United States of America, 2008, Sep-30, Volume: 105, Issue:39

    Topics: Adenosine; Adenosine Deaminase; Adult; Animals; Anticonvulsants; Cerebral Cortex; Epilepsy; Female; GABA-A Receptor Agonists; gamma-Aminobutyric Acid; Humans; Male; Neurons; Oocytes; Purinergic P1 Receptor Antagonists; Pyramidal Tracts; Pyrimidines; Quinazolines; Rats; Receptors, GABA-A; Triazoles; Xanthines; Xenopus

2008
The effect of adenosine on pro-inflammatory cytokine production by porcine T cells.
    Veterinary immunology and immunopathology, 2012, Jan-15, Volume: 145, Issue:1-2

    Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; CD3 Complex; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Concanavalin A; Dose-Response Relationship, Drug; Flow Cytometry; Inflammation; Interferon-gamma; Interleukin-10; Interleukin-2; Quinazolines; Swine; T-Lymphocyte Subsets; T-Lymphocytes; Triazoles; Tumor Necrosis Factor-alpha

2012
Reactive oxygen species contribute to the promotion of the ATP-mediated proliferation of mouse skeletal myoblasts.
    Free radical biology & medicine, 2012, Oct-01, Volume: 53, Issue:7

    Topics: Adenosine Triphosphate; Animals; Calcium; Catalase; Cell Proliferation; Hydrogen Peroxide; Male; Mice; Mice, Inbred BALB C; Myoblasts, Skeletal; Primary Cell Culture; Purinergic P1 Receptor Antagonists; Purinergic P2 Receptor Antagonists; Quinazolines; Reactive Oxygen Species; Receptors, Purinergic P1; Receptors, Purinergic P2; Signal Transduction; Suramin; Triazoles

2012
Identification of a small molecule PriA helicase inhibitor.
    Biochemistry, 2012, Dec-21, Volume: 51, Issue:51

    Topics: Adenosine Triphosphate; Binding Sites; DNA Helicases; DNA-Binding Proteins; Enzyme Inhibitors; Escherichia coli Proteins; Inhibitory Concentration 50; Kinetics; Neisseria gonorrhoeae; Protein Conformation; Quinazolines; Triazoles

2012
Caffeine and the analog CGS 15943 inhibit cancer cell growth by targeting the phosphoinositide 3-kinase/Akt pathway.
    Cancer biology & therapy, 2014, Volume: 15, Issue:5

    Topics: Antineoplastic Agents; Apoptosis; Caffeine; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Proliferation; Humans; Liver Neoplasms; Pancreatic Neoplasms; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Purinergic P1 Receptor Agonists; Quinazolines; Signal Transduction; Triazoles

2014
The role of activated adenosine receptors in degranulation of human LAD2 mast cells.
    Purinergic signalling, 2014, Volume: 10, Issue:3

    Topics: Animals; Cell Line; Humans; Mast Cells; Mice; Mice, Inbred BALB C; Purinergic P1 Receptor Antagonists; Quinazolines; Receptors, Purinergic P1; Triazoles

2014
Methylxanthine reversal of opioid-induced respiratory depression in the neonatal rat: mechanism and location of action.
    Respiratory physiology & neurobiology, 2014, Aug-15, Volume: 200

    Topics: Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Antagonists; Animals; Animals, Newborn; Apnea; Brain Stem; Carotid Body; Central Nervous System Stimulants; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Phrenic Nerve; Quinazolines; Rats, Sprague-Dawley; Respiration; Theobromine; Theophylline; Tissue Culture Techniques; Triazoles; Xanthines

2014
Chronic treatment with ticagrelor limits myocardial infarct size: an adenosine and cyclooxygenase-2-dependent effect.
    Arteriosclerosis, thrombosis, and vascular biology, 2014, Volume: 34, Issue:9

    Topics: 6-Ketoprostaglandin F1 alpha; Adenosine; Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Antagonists; Animals; Aspirin; Cardiotonic Agents; Clopidogrel; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Drug Evaluation, Preclinical; Enzyme Induction; Lipoxins; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Nitric Oxide Synthase Type III; Pyrazoles; Quinazolines; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A1; Receptor, Adenosine A2A; Ticagrelor; Ticlopidine; Triazoles; Up-Regulation

2014
Effects of NAD at purine receptors in isolated blood vessels.
    Purinergic signalling, 2015, Volume: 11, Issue:1

    Topics: Acetamides; Animals; Aorta, Thoracic; Coronary Vessels; Male; Mesenteric Arteries; NAD; Palmitoyl Coenzyme A; Purinergic P1 Receptor Antagonists; Purines; Pyrimidines; Quinazolines; Rats; Rats, Wistar; Receptors, Purinergic; Swine; Triazoles; Vasodilation

2015
A HAMP promoter bioassay system for identifying chemical compounds that modulate hepcidin expression.
    Experimental hematology, 2015, Volume: 43, Issue:5

    Topics: Blotting, Western; Bone Morphogenetic Protein 6; Cell Line, Tumor; Cobalt; Gene Expression; Green Fluorescent Proteins; Heparin; Hepcidins; Humans; Interleukin-6; Microscopy, Fluorescence; Oncostatin M; Organic Chemicals; Promoter Regions, Genetic; Pyrazoles; Pyrimidines; Quinazolines; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Small Molecule Libraries; Triazoles

2015
Caffeine Suppresses the Activation of Hepatic Stellate Cells cAMP-Independently by Antagonizing Adenosine Receptors.
    Biological & pharmaceutical bulletin, 2017, Volume: 40, Issue:5

    Topics: Animals; Caffeine; Cells, Cultured; Chelating Agents; Cyclic AMP; Dose-Response Relationship, Drug; Egtazic Acid; Hepatic Stellate Cells; Liver Cirrhosis; Male; MAP Kinase Signaling System; Mice; Phosphodiesterase Inhibitors; Phosphorylation; Quinazolines; Receptors, Purinergic P1; Triazoles

2017
Discovery of small-molecule inhibitors of multidrug-resistance plasmid maintenance using a high-throughput screening approach.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 11-24, Volume: 117, Issue:47

    Topics: Amines; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; Benzimidazoles; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; DNA Replication; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae Infections; Escherichia coli; High-Throughput Screening Assays; Meropenem; Microbial Sensitivity Tests; Mutagenesis, Site-Directed; Plasmids; Quinazolines; Repressor Proteins; Triazoles

2020
Discovery and Mechanistic Characterization of a Select Modulator of AhR-regulated Transcription (SMAhRT) with Anti-cancer Effects.
    Apoptosis : an international journal on programmed cell death, 2021, Volume: 26, Issue:5-6

    Topics: Animals; Antineoplastic Agents; Apoptosis; Aryl Hydrocarbon Receptor Nuclear Translocator; Cell Line, Tumor; Fas Ligand Protein; Humans; Ligands; Mice; Quinazolines; Receptors, Aryl Hydrocarbon; Signal Transduction; Small Molecule Libraries; Transcriptional Activation; Triazoles

2021